Anticoagulation with heparin during cardiac catheterization and its reversal by protamine

G. J. Dehmer, D. Haagen, C. R. Malloy, J. M. Schmitz

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The duration of effective anticoagulation with heparin during cardiac catheterization and angiography was determined in 201 patients. Effective anticoagulation was defined as prolongation of the activated partial thromboplastin time (APTT) by 2 or more times the upper limit of normal. When the procedure was completed within 40 min of heparin administration, all patients were anticoagulated adequately. The incidence of inadequate anticoagulation ranged from 9% to 25% as the time from heparin administration increased to 89 min. Procedures completed more than 90 min after heparin administration had a 58% incidence of inadequate anticoagulation. A protocol to estimate the appropriate protamine dose was developed based on experience accumulated in the first 78 patients and tested subsequently in 101 consecutive patients. Clotting studies returned to the normal range in 92% of the patients. The mean APTT decreased from 84.1 ± 19.4 to 27.4 ± 2.5 sec (p < .001) after protamine. Patients who did not correct to normal after protamine remained only 2.8 ± 1.4 sec (range 0.7-5.5 sec) above normal. These data provide an estimate of the duration of anticoagulation during cardiac catheterization and angiography and demonstrate the feasibility of a simple and reliable method to reverse the effects of heparin.

Original languageEnglish (US)
Pages (from-to)16-21
Number of pages6
JournalCatheterization and Cardiovascular Diagnosis
Volume13
Issue number1
StatePublished - 1987

Fingerprint

Protamines
Cardiac Catheterization
Heparin
Partial Thromboplastin Time
Angiography
Incidence
Reference Values

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Anticoagulation with heparin during cardiac catheterization and its reversal by protamine. / Dehmer, G. J.; Haagen, D.; Malloy, C. R.; Schmitz, J. M.

In: Catheterization and Cardiovascular Diagnosis, Vol. 13, No. 1, 1987, p. 16-21.

Research output: Contribution to journalArticle

@article{c6cc3998ed9145b283c583cb57113c72,
title = "Anticoagulation with heparin during cardiac catheterization and its reversal by protamine",
abstract = "The duration of effective anticoagulation with heparin during cardiac catheterization and angiography was determined in 201 patients. Effective anticoagulation was defined as prolongation of the activated partial thromboplastin time (APTT) by 2 or more times the upper limit of normal. When the procedure was completed within 40 min of heparin administration, all patients were anticoagulated adequately. The incidence of inadequate anticoagulation ranged from 9{\%} to 25{\%} as the time from heparin administration increased to 89 min. Procedures completed more than 90 min after heparin administration had a 58{\%} incidence of inadequate anticoagulation. A protocol to estimate the appropriate protamine dose was developed based on experience accumulated in the first 78 patients and tested subsequently in 101 consecutive patients. Clotting studies returned to the normal range in 92{\%} of the patients. The mean APTT decreased from 84.1 ± 19.4 to 27.4 ± 2.5 sec (p < .001) after protamine. Patients who did not correct to normal after protamine remained only 2.8 ± 1.4 sec (range 0.7-5.5 sec) above normal. These data provide an estimate of the duration of anticoagulation during cardiac catheterization and angiography and demonstrate the feasibility of a simple and reliable method to reverse the effects of heparin.",
author = "Dehmer, {G. J.} and D. Haagen and Malloy, {C. R.} and Schmitz, {J. M.}",
year = "1987",
language = "English (US)",
volume = "13",
pages = "16--21",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Anticoagulation with heparin during cardiac catheterization and its reversal by protamine

AU - Dehmer, G. J.

AU - Haagen, D.

AU - Malloy, C. R.

AU - Schmitz, J. M.

PY - 1987

Y1 - 1987

N2 - The duration of effective anticoagulation with heparin during cardiac catheterization and angiography was determined in 201 patients. Effective anticoagulation was defined as prolongation of the activated partial thromboplastin time (APTT) by 2 or more times the upper limit of normal. When the procedure was completed within 40 min of heparin administration, all patients were anticoagulated adequately. The incidence of inadequate anticoagulation ranged from 9% to 25% as the time from heparin administration increased to 89 min. Procedures completed more than 90 min after heparin administration had a 58% incidence of inadequate anticoagulation. A protocol to estimate the appropriate protamine dose was developed based on experience accumulated in the first 78 patients and tested subsequently in 101 consecutive patients. Clotting studies returned to the normal range in 92% of the patients. The mean APTT decreased from 84.1 ± 19.4 to 27.4 ± 2.5 sec (p < .001) after protamine. Patients who did not correct to normal after protamine remained only 2.8 ± 1.4 sec (range 0.7-5.5 sec) above normal. These data provide an estimate of the duration of anticoagulation during cardiac catheterization and angiography and demonstrate the feasibility of a simple and reliable method to reverse the effects of heparin.

AB - The duration of effective anticoagulation with heparin during cardiac catheterization and angiography was determined in 201 patients. Effective anticoagulation was defined as prolongation of the activated partial thromboplastin time (APTT) by 2 or more times the upper limit of normal. When the procedure was completed within 40 min of heparin administration, all patients were anticoagulated adequately. The incidence of inadequate anticoagulation ranged from 9% to 25% as the time from heparin administration increased to 89 min. Procedures completed more than 90 min after heparin administration had a 58% incidence of inadequate anticoagulation. A protocol to estimate the appropriate protamine dose was developed based on experience accumulated in the first 78 patients and tested subsequently in 101 consecutive patients. Clotting studies returned to the normal range in 92% of the patients. The mean APTT decreased from 84.1 ± 19.4 to 27.4 ± 2.5 sec (p < .001) after protamine. Patients who did not correct to normal after protamine remained only 2.8 ± 1.4 sec (range 0.7-5.5 sec) above normal. These data provide an estimate of the duration of anticoagulation during cardiac catheterization and angiography and demonstrate the feasibility of a simple and reliable method to reverse the effects of heparin.

UR - http://www.scopus.com/inward/record.url?scp=0023158247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023158247&partnerID=8YFLogxK

M3 - Article

C2 - 3815512

AN - SCOPUS:0023158247

VL - 13

SP - 16

EP - 21

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 1

ER -